On Nov 05, major Wall Street analysts update their ratings for $Ceribell (CBLL.US)$, with price targets ranging from $30 to $32.
J.P. Morgan analyst Robbie Marcus initiates coverage with a buy rating, and sets the target price at $32.
BofA Securities analyst Travis Steed initiates coverage with a buy rating, and sets the target price at $32.
TD Cowen analyst Josh Jennings initiates coverage with a buy rating, and sets the target price at $31.
William Blair analyst Margaret Kaczor initiates coverage with a buy rating.
CCORF analyst William Plovanic initiates coverage with a buy rating, and sets the target price at $30.
Furthermore, according to the comprehensive report, the opinions of $Ceribell (CBLL.US)$'s main analysts recently are as follows:
Ceribell has created a unique, easily transportable/disposable hardware and advanced AI-driven software intended for the diagnosis and ongoing monitoring of patients with non-convulsive seizures in a hospital environment. With a recurring revenue model that generates a leading gross margin profile in the MedTech industry of 85%, and visibility into a 30% revenue growth trajectory over the forthcoming five years, there is confidence in the company's potential to realize significant operating leverage and cash flow production over time.
Ceribell's technology addresses the challenges faced by traditional EEG in the acute care environment, providing workflow improvements for physicians and staff, as well as financial advantages for hospitals.
Here are the latest investment ratings and price targets for $Ceribell (CBLL.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
